# Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients

> **NCT06661655** · NA · RECRUITING · sponsor: **E-Scopics** · enrollment: 120 (estimated)

## Conditions studied

- Metabolic Syndrome X
- Fatty Liver
- MASH - Metabolic Dysfunction-Associated Steatohepatitis
- MASLD
- NASH (Non-Alcoholic Steatohepatitis)
- Steatosis, Liver
- NAFLD

## Interventions

- **DEVICE:** Liver ultrasound

## Key facts

- **NCT ID:** NCT06661655
- **Lead sponsor:** E-Scopics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-24
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06661655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06661655, "Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06661655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*